Immuron Limited (ASX:IMC)
Australia · Delayed Price · Currency is AUD 0.0480
+0.0020 (4.35%)
Sep 18, 2026, 2:36 PM AEST
Immuron Market Cap
Immuron has a market cap or net worth of 14.85 million as of September 17, 2026. Its market cap has decreased by -24.15% in one year.
Market Cap
14.85M
Enterprise Value
6.02M
Revenue
7.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
ChartMarket Cap Chart
Since September 14, 1999, Immuron's market cap has decreased from 37.31M to 14.85M, a decrease of -60.19%. That is a compound annual growth rate of -3.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 14.85M | 26.73% |
| Dec 31, 2025 | 11.72M | -35.27% |
| Dec 30, 2024 | 18.10M | 3.20% |
| Dec 29, 2023 | 17.54M | -10.47% |
| Dec 30, 2022 | 19.59M | -14.00% |
| Dec 31, 2021 | 22.78M | -56.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Noxopharm | 23.04M |
| Imugene | 23.02M |
| NeuroScientific Biopharmaceuticals | 22.99M |
| Argenica Therapeutics | 22.48M |
| EZZ Life Science Holdings | 20.47M |
| Algorae Pharmaceuticals | 18.25M |
| Neurotech International | 17.20M |
| Ceryvyn Therapeutics | 13.68M |